Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis-Reference-Cited by-同舟云学术

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis

Published:2009-03 Issue:3 Volume:39 Page:387-393
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:

Author:

Malling H-J.,Montagut A.,Melac M.,Patriarca G.,Panzner P.,Seberova E.,Didier A.

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2222.2008.03152.x/fullpdf

Reference18 articles.

1. 1 Plaut M , Valentine MD. Clinical practice. Allergic rhinitis. N Engl J Med 2005; 353:1934-44.

2. 2 Bousquet J , Khaltaev N , Cruz AA et al. Allergic rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN* and AllerGen**). Allergy 2008; 63 (Suppl 86):8-160.

3. 3 Bauchau V , Durham SR. Prevalence and rate of diagnosis of allergic rhinitis. Eur Resp J 2004; 24:758-64.

4. 4 Bauchau V , Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005; 60:350-3.

5. 5 Bousquet J , Neukirch F , Bousquet PJ et al. Severity and impairment of allergic rhinitis in patients consulting in primary care. J Allergy Clin Immunol 2006; 117:158-62.

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Art of Dosing for Subcutaneous Immunotherapy in North America;The Journal of Allergy and Clinical Immunology: In Practice;2024-01

2. Pre-seasonal immunotherapy is effective in both monosensitized and polysensitized patients with allergic rhinitis;European Annals of Allergy and Clinical Immunology;2023-05

3. Extrapolating Evidence-Based Medicine of AIT Into Clinical Practice in the United States;The Journal of Allergy and Clinical Immunology: In Practice;2023-04

4. International consensus statement on allergy and rhinology: Allergic rhinitis – 2023;International Forum of Allergy & Rhinology;2023-03-06

5. Update about Oralair® as a treatment for grass pollen allergic rhinitis;Human Vaccines & Immunotherapeutics;2022-06-15